IP Library Granted Patent US 8,956,863
Granted Patent B2
US 8,956,863 · App. 13/501,475 · Granted Feb 17, 2015

Agents from cells

Inventors: Jeffrey M. Karp (Brookline, MA); Debanjan Sarkar (Williamsville, NY); Praveen Kumar Vemula (Cambridge, MA)
Assignee: The Brigham and Women's Hospital, Inc.
A61K47/48853A61K38/1816A61K47/48907
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,956,863
App. No.
13/501,475
Granted
Feb 17, 2015
Kind
B2
Abstract

A composition includes an isolated cell; at least one particle within said cell; and at least one active agent associated with the particle, wherein the active agent is capable of being released from the cell. A method includes administration of such a cell to a subject.

Claims (17)

1. A composition comprising:

a) an isolated mammalian cell;

b) at least one particle comprising a polymer and having a size of about 1 μm to 2 μm within the cell; and

c) at least one active agent associated with the particle;

wherein the active agent is capable of being released from inside the cell independently of the particle.

2. The composition of claim 1 , wherein the particle is formulated to release the agent into the cell in a controlled or predictable manner.

3. The composition of claim 1 , wherein the particle is formulated to release the agent to the extracellular environment.

4. The composition of claim 1 , wherein the agent is a therapeutic agent, diagnostic agent, imaging agent, chemoattractant, homing agent, immunomodulator, cytotoxic agent, or an angiogenesis inhibitor.

5. The composition of claim 1 , wherein the agent is covalently attached to the particle.

6. The composition of claim 1 , wherein the agent is noncovalently entrapped in the particle.

7. The composition of claim 1 , wherein the cell is a stem cell or a progenitor cell.

8. The composition of claim 1 , further comprising at least one extracellular particle not on or within the cell.

9. The composition of claim 8 , wherein the at least one extracellular particle is associated with an encapsulating material.

10. The composition of claim 1 , wherein the composition is cryopreserved.

11. The composition of claim 7 , wherein the stem cell is a mesenchymal stem cell.

12. The composition of claim 1 , wherein the polymer is poly (lactide-co-glycolide).

13. The composition of claim 1 , wherein the particle is formulated to release the agent from inside the cell over a period of at least 10 days.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 10, 2018
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 047758/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2012
From: KARP, JEFFREY M.; SARKAR, DEBANJAN; VEMULA, PRAVEEN KUMAR
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 028459/0125 →
Continuity (3)
Provisional Application 61251801 · Oct 15, 2009
Provisional Application 61387242 · Sep 28, 2010
Related Publication 20120263765A1 · Oct 18, 2012